Literature DB >> 8604744

The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy.

P J Botelho1, L N Johnson, A C Arnold.   

Abstract

PURPOSE: To examine the effect of aspirin use on the visual outcome of nonarteritic anterior ischemic optic neuropathy.
METHODS: This retrospective case-controlled study included 23 patients who used aspirin regularly before and during the course of nonarteritic anterior ischemic optic neuropathy and 55 control patients with nonarteritic anterior ischemic optic neuropathy. Snellen visual acuity in logMAR and mean deviation on automated perimetry were compiled from the initial and final follow-up examinations.
RESULTS: The comparisons of patients who took aspirin with control patients disclosed that neither initial logMAR (P = .36) nor the follow-up logMAR (P = .95) data differed significantly. There was no significant difference between the groups for the initial (P = .60) and the follow-up mean deviation (P = .41).
CONCLUSIONS: Aspirin use does not improve the visual outcome of patients with nonarteritic anterior ischemic optic neuropathy. Additional studies are needed to further elucidate this issue.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604744     DOI: 10.1016/s0002-9394(14)70448-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  12 in total

1.  Non-arteritic anterior ischemic optic neuropathy and thrombophilia.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

2.  Levodopa as a possible treatment of visual loss in nonarteritic anterior ischemic optic neuropathy.

Authors:  Deanna P Lyttle; Lenworth N Johnson; Edward A Margolin; Richard W Madsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-20       Impact factor: 3.117

3.  Bilateral Simultaneous Nonarteritic Anterior Ischaemic Optic Neuropathy: Case Report.

Authors:  Fatih C Gundogan; Soner Guven; Umit Yolcu; Sabahattin Sari; Gungor Sobaci
Journal:  Neuroophthalmology       Date:  2013-09-24

4.  Nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins
Journal:  Curr Treat Options Neurol       Date:  2011-02       Impact factor: 3.598

Review 5.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

6.  Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study.

Authors:  Barbara Giambene; Andrea Sodi; Francesco Sofi; Rossella Marcucci; Sandra Fedi; Rosanna Abbate; Domenico Prisco; Ugo Menchini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

7.  Intravitreal bevacizumab for the treatment of nonarteritic anterior ischemic optic neuropathy: a prospective trial.

Authors:  D B Rootman; H S Gill; E A Margolin
Journal:  Eye (Lond)       Date:  2013-02-01       Impact factor: 3.775

8.  The effect of high-dose steroids, and normobaric oxygen therapy, on recent onset non-arteritic anterior ischemic optic neuropathy: a randomized clinical trial.

Authors:  Mohammad Pakravan; Nasrin Sanjari; Hamed Esfandiari; Parastou Pakravan; Mehdi Yaseri
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-10       Impact factor: 3.117

9.  Management of ischemic optic neuropathies.

Authors:  Sohan Singh Hayreh
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

10.  Visual outcome of mega-dose intravenous corticosteroid treatment in non-arteritic anterior ischemic optic neuropathy - retrospective analysis.

Authors:  Michael Kinori; Iris Ben-Bassat; Yael Wasserzug; Angela Chetrit; Ruth Huna-Baron
Journal:  BMC Ophthalmol       Date:  2014-05-03       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.